These effects may ultimately increase the risk for subacute radiation pneumonitis, particularly when tissue tolerance to the inflammatory insult from chemo-radiotherapy is additionally challenged by inhibition of PD-1/PD-L1 signaling. The gene discussed is CD274; the disease is radiation pneumonitis.